122 Infectious Diseases and Geographic Medicine Division Grand Rounds: " “COVID-19 Treatment with Monoclonal/Polyclonal Antibodies and Impact of Variants: What we have learned in Hospitalized Patients”(020322)
Dallas, TX US
February 3, 2022
To provide ID faculty and others with updates of interdepartmental research with research and clinical lectures for visiting faculty, and with didactic updates of the latest new trends and topics within the field of infectious diseases
Target Audience
ID Faculty, ID fellows, medical students, residents and pharmacists and staff
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Identify and describe new trends in HIV medicine, transplant infectious diseases and global health-related infectious diseases
- Identify and describe new trends and policies in hospital epidemiology, infection prevention and control, and antibiotic stewardship
- Identify and describe evolving changes in infectious disease diagnostics, therapeutics, and management
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Y9.404
Dallas, TX
75390
United States
Speaker(s)
Mamta Jain, MD, MPH
has a financial relationship (Grant Or Contract) with Gilead Sciences ;.
has a financial relationship (Grant Or Contract) with Regeneron;.
has a financial relationship (Grant Or Contract) with GlaxoSmithKline;.
has a financial relationship (Professional Services) with ACTHIV;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Professional Services) with Gilead Sciences ;.
has a financial relationship (Grant Or Contract) with Janssen;.
has a financial relationship (Grant Or Contract) with Vasogene;.
Available Credit
- 1.00 AMA
- 1.00 Attendance
Price
Cost:
$0.00
Please login or create an account to take this course.